These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


468 related items for PubMed ID: 28621736

  • 1. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
    Daniel R, Wu Q, Williams V, Clark G, Guruli G, Zehner Z.
    Int J Mol Sci; 2017 Jun 16; 18(6):. PubMed ID: 28621736
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
    Rodríguez M, Bajo-Santos C, Hessvik NP, Lorenz S, Fromm B, Berge V, Sandvig K, Linē A, Llorente A.
    Mol Cancer; 2017 Oct 05; 16(1):156. PubMed ID: 28982366
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
    Dülgeroğlu Y, Eroğlu O.
    Microrna; 2020 Oct 05; 9(4):303-309. PubMed ID: 33155933
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S, Yi XM, Zhou WQ, Cheng W, Ge JP, Zhang ZY.
    Int J Clin Exp Pathol; 2015 Oct 05; 8(11):14335-44. PubMed ID: 26823749
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of microRNA signature and potential pathway targets in prostate cancer.
    Moustafa AA, Ziada M, Elshaikh A, Datta A, Kim H, Moroz K, Srivastav S, Thomas R, Silberstein JL, Moparty K, Salem FE, El-Habit OH, Abdel-Mageed AB.
    Exp Biol Med (Maywood); 2017 Mar 05; 242(5):536-546. PubMed ID: 27903835
    [Abstract] [Full Text] [Related]

  • 16. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
    Tinay I, Tan M, Gui B, Werner L, Kibel AS, Jia L.
    Prostate; 2018 Sep 01; 78(12):927-937. PubMed ID: 29748958
    [Abstract] [Full Text] [Related]

  • 19. Circulating MicroRNAs in blood of patients with prostate cancer.
    Medina-Villaamil V, Martínez-Breijo S, Portela-Pereira P, Quindós-Varela M, Santamarina-Caínzos I, Antón-Aparicio LM, Gómez-Veiga F.
    Actas Urol Esp; 2014 Dec 01; 38(10):633-9. PubMed ID: 24661838
    [Abstract] [Full Text] [Related]

  • 20. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G, Qu A, Wang H, Wang L, Zhang X, Liu H, Pan H, Yang Y, Wang C.
    Mol Med Rep; 2015 Jul 01; 12(1):615-22. PubMed ID: 25738263
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.